RANKL (Denosumab biosimilar) Antibody from ICHORBIO
Search, find, compare suppliers for anti-RANKL (Denosumab biosimilar) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | RANKL (Denosumab biosimilar) |
| Clone | monoclonal |
| Host Species | Humanized |
| Reactive Species | human |
| Isotype | IgG2 |
| Format | Protein A/G purified, low endotoxin |
| Size | 50mg |
| Concentration | 1.0 - 5.0 mg/ml |
| Applications | RUO |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: detects human RANK Ligand. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Denosumab. Denosumab biosimilar is a human IgG2 monoclonal antibody that binds to human RANKL. Denosumab has an approximate molecular weight of 147 kDa and is produced in genetically engineered mammalian (Chinese hamster ovary) cells. |
| Immunogen | n/a |
| Other Names | Tumor necrosis factor ligand superfamily member 11, Tnfsf11, Osteoclast differentiation factor, ODF, Osteoprotegerin ligand, OPGL, Receptor activator of nuclear factor kappa-B ligand, TNF-related activation-induced cytokine, TRANCE, CD254, Rank Ligang |
| Gene, Accession # | UniProt: O14788 |
| Catalog # | ICH4019-50mg |
| Price | $3750 |
| Order / More Info | RANKL (Denosumab biosimilar) Antibody from ICHORBIO |
| Product Specific References | RANKL neutralisation prevents osteoclast activation in a human in vitro ameloblastoma-bone model: https://journals.sagepub.com/doi/pdf/10.1177/20417314221140500 |
ICHORBIO
ICHORBIO
Boston House, Grove Business Park
Downsview Road
Wantage OX12 9FF ENGLAND
orders@ichor.bio
https://ichor.bio
U.S. OFFICE
987 Old Eagle School Rd, Ste 709
Wayne, PA 19087
us@ichor.bio
Profile of ICHORBIO
Return to Antibodies